Nano-phytophospholipid composition and the method of preparation thereof. The composition of nano-phytophospholipid comprises of active agent(s) and phospholipid(s) in a weight ratio of 1:0.001-20, a surfactant ranging from 0.001-60% by weight of the composition, a super disintegrant/ disintegrant at 0.001-25% by we...
Elastic nano-vesicles for co-delivery of antiglaucoma agents and siRNA for treatment of glaucoma and method of preparing thereof. The present invention relates to development of elastic nano-vesicles containing anti-glaucoma drug (with and without dendrimeric peptide) and elastic nano-vesicles containing siRNA (with...
Anti-psoriasis topical formulation containing combination drugs and method of preparation thereof. The present invention relates to microsponge (MS) based anti-psoriasis topical formulation (gel) containing combination drugs (Apremilast and Betamethasone dipropionate anddendrimeric peptide or amino acid(s) for enhan...
[Class : 5] Pharmaceuticals, Pharmaceutical Preparations, Veterinary Preparations, Herbal Extracts For Medical Purposes, Plant Extracts For Pharmaceutical Purposes, Biological Preparations For Medical, Veterinary And Pharmaceutical Purposes, Medicinal Herbs, Medicines For Human And Veterinary Purposes, Chemical Preparations For Medical And Pharmaceutical Purposes Included In...
[Class : 3] Cosmetics And Cosmetic Preparations, Herbal Extracts For Cosmetic Purposes And Extracts Of Flowers, Oils For Cosmetic And Cleaning Purposes, Toiletry Preparations Included In Class 03
Documents
List of Directors;-30012023
List of share holders, debenture holders;-30012023
Form MGT-7A-30012023_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-28012023
Directors report as per section 134(3)-28012023
Form AOC-4-28012023_signed
Form ADT-1-14012023_signed
Copy of resolution passed by the company-14012023
Copy of written consent given by auditor-14012023
Form DPT-3-29062022
Form MGT-14-13042022_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-13042022
Optional Attachment-(1)-13042022
Form DIR-12-13042022_signed
Form DIR-12-03042022_signed
Optional Attachment-(2)-24032022
Optional Attachment-(1)-24032022
Interest in other entities;-24032022
Declaration of the appointee director, Managing director, in Form No. DIR-2;-24032022
Acknowledgement received from company-03012022
Proof of dispatch-03012022
Optional Attachment-(1)-03012022
Notice of resignation;-03012022
Notice of resignation filed with the company-03012022